新锐医药国际控股有限公司（股票代码：06108）于2026年8月3日公布截至2026年7月31日止的证券变动月报表。该报告显示，公司截至报告期末的法定注册股本为15,000,000,000股，面值每股0.01港元，对应总额150,000,000港元。本期法定注册股本与上月一致。
本期公司已发行普通股（不含库存股）数量为200,616,665股，较上月无增减变动，库存股数量亦保持为0股。本月未发生任何新增发行、回购、注销或库存股份变动。
在股份期权方面，公司于2013年10月通过的购股权计划共授出12,820,000份认股权证，本月内相应数目未发生变动。当月亦无其他可换股票据、新增发行及库藏股相关活动。
公司表示，将继续严格遵守香港联交所《上市规则》及相关法律法规。公告由公司秘书吴日升签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.